Authors: Landau, A Batisse, D Piketty, C Van Huyen, LPD Bloch, F Belec, L Bruneval, P Weiss, L Jian, R Kazatchkine, MD

Citation: A. Landau et al., Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients, AIDS, 15(16), 2001, pp. 2149-2155

Authors: Landau, A Batisse, D Van Huyen, JPD Piketty, C Bloch, F Pialoux, G Belec, L Petite, JP Weiss, L Kazatchkine, M

Citation: A. Landau et al., Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients, AIDS, 14(7), 2000, pp. 839-844

Authors: Landau, A Batisse, D Piketty, C Jian, R Kazatchkine, MD

Citation: A. Landau et al., Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy, AIDS, 14(12), 2000, pp. 1857-1858

Authors: Landau, A Batisse, D Piketty, C Kazatchkine, MD

Citation: A. Landau et al., Effect of interferon and ribavirin on HIV viral load, AIDS, 14(1), 2000, pp. 96-97

Authors: Meynard, JL Barbut, F Guiguet, M Batisse, D Lalande, V Lesage, D Guiard-Schmid, JB Petit, JC Frottier, J Meyohas, MC

Citation: Jl. Meynard et al., Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients, J INFECTION, 38(3), 1999, pp. 176-181